Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery
1 other identifier
interventional
99
1 country
1
Brief Summary
The aim of this study is to investigate the point or nonsense of treating cartilage lesions at the level of the first metatarsophalane joint. To date, no clear guidelines have been found in the literature with regard to the treatment of cartilage lesions at the MTP I joint during corrective surgery for hallux valgus, nor has it been investigated whether this can have an effect on the clinical outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2020
CompletedFirst Submitted
Initial submission to the registry
November 9, 2020
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedMarch 12, 2025
March 1, 2025
5.3 years
November 9, 2020
March 10, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Change in AOFAS
American Orthopaedic Foot and Ankle Society (AOFAS) score - combines a clinician-reported and a patient-reported part for measuring the outcome of treatment in patients who sustained a complex hindfoot injury based on pain, function and alignment: 0 (bad outcome) to 100 (very good outcome)
10 days, 5 weeks, 4 months, 1 year
Change in SF36
Short Form 36 (SF-36) Health Survey - consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
10 days, 5 weeks, 4 months, 1 year
Change in VAS pain
Visual Analogue Scale pain score - 0 (no pain) to 10 (worse pain)
10 days, 5 weeks, 4 months, 1 year
Secondary Outcomes (1)
Change in VAS Patient satisfaction
10 days, 5 weeks, 4 months, 1 year
Study Arms (3)
MTP1 joint with no cartillage laesion or grade I
NO INTERVENTIONPatients in whom no treatment of the cartilage lesions is performed: these patients have no cartilage lesion or a grade I cartilage lesion at the MTP I joint that has been found peroperatively. The degree of the cartilage lesions will be determined on the basis of the ICRS scale and an MS Hololens.
MTP1 joint with cartillage laesion > grade I - non treatment
NO INTERVENTIONPatients in whom a cartilage lesion\> grade 1 is found during surgery randomised in the no treatment group
MTP1 joint with cartillage laesion > grade I - treatment
EXPERIMENTALPatients in whom a cartilage lesion\> grade 1 is found during surgery randomised in the treatment group. They will be treated through debridement of the lesion and microfracture.
Interventions
Patients with a MTP1 cartillage lesion \> grade I (based on based on the ICRS scale and an MS HoloLens measurement) randomised in the treatment group will be treated with debridement and microfracture
Eligibility Criteria
You may qualify if:
- hallux valgus
You may not qualify if:
- younger than 30 years, older than 60 years
- extra pathologies other than hallux valgus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tom Lootenslead
Study Sites (1)
AZ Maria Middelares
Ghent, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
November 9, 2020
First Posted
January 20, 2021
Study Start
September 15, 2020
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
March 12, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share